Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma.
Borch TH, Harbst K, Rana AH, Andersen R, Martinenaite E, Kongsted P, Pedersen M, Nielsen M, Kjeldsen JW, Kverneland AH, Lauss M, Hölmich LR, Hendel H, Met Ö, Jönsson G, Donia M, Svane IM.
Borch TH, et al. Among authors: donia m.
J Immunother Cancer. 2021 Jul;9(7):e002703. doi: 10.1136/jitc-2021-002703.
J Immunother Cancer. 2021.
PMID: 34210820
Free PMC article.